Ambarella Inc: Form 10-Q for the period ended Apr 30, 2021
Filed with the SEC on Jun 8, 2021 and accepted by EDGAR at Jun 8, 2021, 13:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-02-01 to 2021-04-30 | $70.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-02-01 to 2021-04-30 | $26.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-02-01 to 2021-04-30 | $43.8m | us-gaap:GrossProfit |
| Research and development | 3 months2021-02-01 to 2021-04-30 | $37.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-02-01 to 2021-04-30 | $16.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-02-01 to 2021-04-30 | −$10.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-02-01 to 2021-04-30 | $1.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-02-01 to 2021-04-30 | −$10.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-02-01 to 2021-04-30 | −$0.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-02-01 to 2021-04-30 | −$0.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-02-01 to 2021-04-30 | 35,940,304 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2021-02-01 to 2021-04-30 | −$4.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-02-01 to 2021-04-30 | $2.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 3 months2021-02-01 to 2021-04-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-04-30 | $227.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-04-30 | $508.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-04-30 | $584.6m | us-gaap:Assets |
| Current liabilities | At period end2021-04-30 | $70.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-04-30 | $93.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-04-30 | $491.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-21-032072. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.